Laura Barrow

A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation

Philip B. Miner, William Koltun, Gregory Wiener et al. · The American Journal of Gastroenterology · 2017 · 141 citations

Medicine, Pharmacology, Pharmacotherapy +17

Plecanatide, an Oral Guanylate Cyclase C Agonist Acting Locally in the Gastrointestinal Tract, Is Safe and Well-Tolerated in Single Doses

Kunwar Shailubhai, Stephen Comiskey, John A. Foss et al. · Digestive Diseases and Sciences · 2013 · 98 citations

Medicine, Pharmacology, Pharmacotherapy +4

Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation

Michael DeMicco, Laura Barrow, Bernadette Hickey et al. · Therapeutic Advances in Gastroenterology · 2017 · 75 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Plecanatide, a Novel Uroguanylin Analog: A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate Efficacy and Safety in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Philip B. Miner, Robert DeLuca, Marianela La Portilla et al. · The American Journal of Gastroenterology · 2014 · 33 citations

Medicine, Pharmacology, Pharmacotherapy +14

925g Plecanatide, a Novel Guanylate Cyclase-C (GC-C) Receptor Agonist, is Efficacious and Safe in Patients with Chronic Idiopathic Constipation (CIC): Results from a 951 Patient, 12 Week, Multi-Center Trial

Philip B. Miner, Ron Surowitz, Ron Fogel et al. · Gastroenterology · 2013 · 32 citations

Medicine, Pharmacology, Pharmacotherapy +16